Clinical Trial Update: Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating roflumilast on quality of life, lung function, and mucus properties in adults with bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Bronchiectasis Adult | Phase 2 | Status: UNKNOWN